{"id":"https://openalex.org/W2121663010","doi":"https://doi.org/10.1056/nejmoa1215372","title":"Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria","display_name":"Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria","publication_year":2013,"publication_date":"2013-02-24","ids":{"openalex":"https://openalex.org/W2121663010","doi":"https://doi.org/10.1056/nejmoa1215372","mag":"2121663010","pmid":"https://pubmed.ncbi.nlm.nih.gov/23432142"},"language":"en","primary_location":{"id":"doi:10.1056/nejmoa1215372","doi":"https://doi.org/10.1056/nejmoa1215372","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejmoa1215372","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMoa1215372?articleTools=true","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMoa1215372?articleTools=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091156366","display_name":"Marcus Maurer","orcid":"https://orcid.org/0000-0002-4121-481X","observed_orcids":["https://orcid.org/0000-0002-4121-481X"]},"institutions":[{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Marcus Maurer","raw_affiliation_strings":["Department of Dermatology and Allergy, Charit\u00e9-Universit\u00e4tsmedizin, Berlin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology and Allergy, Charit\u00e9-Universit\u00e4tsmedizin, Berlin","institution_ids":["https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112132692","display_name":"Karin E. Ros\u00e9n","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":[],"is_corresponding":false,"raw_author_name":"Karin Ros\u00e9n","raw_affiliation_strings":["Genentech, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039075235","display_name":"Hsin-Ju Hsieh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":[],"is_corresponding":false,"raw_author_name":"Hsin-Ju Hsieh","raw_affiliation_strings":["Genentech, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065711815","display_name":"Sarbjit S. Saini","orcid":"https://orcid.org/0000-0001-8522-2742","observed_orcids":["https://orcid.org/0000-0001-8522-2742"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarbjit Saini","raw_affiliation_strings":["Johns Hopkins Asthma and Allergy Center, Baltimore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins Asthma and Allergy Center, Baltimore","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075210050","display_name":"Clive Grattan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799472390","display_name":"Norfolk and Norwich University Hospital","ror":"https://ror.org/021zm6p18","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799472390","https://openalex.org/I2800371493"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Clive Grattan","raw_affiliation_strings":["Department of Dermatology, Norfolk and Norwich University Hospital, Norwich"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Norfolk and Norwich University Hospital, Norwich","institution_ids":["https://openalex.org/I2799472390"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062536923","display_name":"Ana Maria Gim\u00e9nez\u2010Arnau","orcid":"https://orcid.org/0000-0001-5434-7753","observed_orcids":["https://orcid.org/0000-0001-5434-7753","https://orcid.org/0009-0009-6824-7687","https://orcid.org/0000-0002-3898-0652"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ana Gimen\u00e9z-Arnau","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041839845","display_name":"Sunil K Agarwal","orcid":"https://orcid.org/0000-0003-2656-1861","observed_orcids":["https://orcid.org/0000-0003-2656-1861"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":[],"is_corresponding":false,"raw_author_name":"Sunil Agarwal","raw_affiliation_strings":["Genentech, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068146106","display_name":"Ramona L. Doyle","orcid":"https://orcid.org/0000-0003-4506-6188","observed_orcids":["https://orcid.org/0000-0003-4506-6188"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":[],"is_corresponding":false,"raw_author_name":"Ramona Doyle","raw_affiliation_strings":["Genentech, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058866214","display_name":"Janice Canvin","orcid":"https://orcid.org/0000-0001-9609-7182","observed_orcids":["https://orcid.org/0000-0001-9609-7182"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Janice Canvin","raw_affiliation_strings":["Novartis Pharmaceuticals, Horsham, West Sussex"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals, Horsham, West Sussex","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053946031","display_name":"Allen P. Kaplan","orcid":"https://orcid.org/0000-0002-6566-4743","observed_orcids":["https://orcid.org/0000-0002-6566-4743"]},"institutions":[{"id":"https://openalex.org/I153297377","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78","country_code":"US","type":"education","lineage":["https://openalex.org/I153297377"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allen Kaplan","raw_affiliation_strings":["Medical University of South Carolina, Charleston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of South Carolina, Charleston","institution_ids":["https://openalex.org/I153297377"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069959810","display_name":"Thomas B. Casale","orcid":"https://orcid.org/0000-0002-3149-7377","observed_orcids":["https://orcid.org/0000-0002-3149-7377"]},"institutions":[{"id":"https://openalex.org/I2800482329","display_name":"CHI Health Creighton University Medical Center - Bergan Mercy","ror":"https://ror.org/03z1w3b90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800482329","https://openalex.org/I2802665030","https://openalex.org/I2802797007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Casale","raw_affiliation_strings":["Creighton University Medical Center, Omaha, NE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Creighton University Medical Center, Omaha, NE","institution_ids":["https://openalex.org/I2800482329"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":72.8306,"has_fulltext":false,"cited_by_count":1107,"citation_normalized_percentile":{"value":0.99992737,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":100},"biblio":{"volume":"368","issue":"10","first_page":"924","last_page":"935"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12438","display_name":"Urticaria and Related Conditions","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12438","display_name":"Urticaria and Related Conditions","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/omalizumab","display_name":"omalizumab","score":0.9700000286102295},{"id":"https://openalex.org/keywords/chronic-spontaneous-urticaria","display_name":"chronic spontaneous urticaria","score":0.9739999771118164},{"id":"https://openalex.org/keywords/anti-ige-monoclonal-antibody","display_name":"anti-IgE monoclonal antibody","score":0.9860000014305115},{"id":"https://openalex.org/keywords/refractory-urticaria","display_name":"refractory urticaria","score":0.6489999890327454},{"id":"https://openalex.org/keywords/antihistamine-therapy","display_name":"antihistamine therapy","score":0.6729999780654907},{"id":"https://openalex.org/keywords/itch-intensity","display_name":"itch severity","score":0.8339999914169312},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.5870000123977661},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8489999771118164},{"id":"https://openalex.org/keywords/mast-cells","display_name":"mast cells","score":0.5889999866485596},{"id":"https://openalex.org/keywords/basophils","display_name":"basophils","score":0.9800000190734863},{"id":"https://openalex.org/keywords/ige-inhibition","display_name":"IgE suppression","score":0.5379999876022339},{"id":"https://openalex.org/keywords/subcutaneous-injection","display_name":"subcutaneous injection","score":0.6940000057220459},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.6769999861717224}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9607429504394531},{"id":"https://openalex.org/C2778564945","wikidata":"https://www.wikidata.org/wiki/Q415392","display_name":"Omalizumab","level":4,"score":0.9600403308868408},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.69492107629776},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6811414957046509},{"id":"https://openalex.org/C2779923671","wikidata":"https://www.wikidata.org/wiki/Q199602","display_name":"Itching","level":2,"score":0.6272903680801392},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5656408667564392},{"id":"https://openalex.org/C2776880894","wikidata":"https://www.wikidata.org/wiki/Q324089","display_name":"Antihistamine","level":2,"score":0.5152730941772461},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.43740808963775635},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4248626232147217},{"id":"https://openalex.org/C141105273","wikidata":"https://www.wikidata.org/wiki/Q79455","display_name":"Immunoglobulin E","level":3,"score":0.39814499020576477},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.2934074401855469},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.25698238611221313},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2018565535545349},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.18473747372627258},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06851911544799805},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069444","descriptor_name":"Omalizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069444","descriptor_name":"Omalizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069444","descriptor_name":"Omalizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000888","descriptor_name":"Antibodies, Anti-Idiotypic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000888","descriptor_name":"Antibodies, Anti-Idiotypic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000888","descriptor_name":"Antibodies, Anti-Idiotypic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000888","descriptor_name":"Antibodies, Anti-Idiotypic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000888","descriptor_name":"Antibodies, Anti-Idiotypic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000888","descriptor_name":"Antibodies, Anti-Idiotypic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014581","descriptor_name":"Urticaria","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D014581","descriptor_name":"Urticaria","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D014581","descriptor_name":"Urticaria","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D014581","descriptor_name":"Urticaria","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014581","descriptor_name":"Urticaria","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014581","descriptor_name":"Urticaria","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D018926","descriptor_name":"Anti-Allergic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018926","descriptor_name":"Anti-Allergic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018926","descriptor_name":"Anti-Allergic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018926","descriptor_name":"Anti-Allergic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018926","descriptor_name":"Anti-Allergic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018926","descriptor_name":"Anti-Allergic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057194","descriptor_name":"Intention to Treat Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057194","descriptor_name":"Intention to Treat Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057194","descriptor_name":"Intention to Treat Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1056/nejmoa1215372","doi":"https://doi.org/10.1056/nejmoa1215372","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejmoa1215372","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMoa1215372?articleTools=true","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},{"id":"pmid:23432142","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23432142","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":{"id":"doi:10.1056/nejmoa1215372","doi":"https://doi.org/10.1056/nejmoa1215372","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejmoa1215372","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMoa1215372?articleTools=true","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.800000011920929}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W2121663010.pdf"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W1748713341","https://openalex.org/W1910182345","https://openalex.org/W1970813603","https://openalex.org/W1988223366","https://openalex.org/W1988932853","https://openalex.org/W2013635715","https://openalex.org/W2015653813","https://openalex.org/W2024045584","https://openalex.org/W2026119244","https://openalex.org/W2031640798","https://openalex.org/W2056866975","https://openalex.org/W2057347176","https://openalex.org/W2058789166","https://openalex.org/W2063316222","https://openalex.org/W2068049003","https://openalex.org/W2081742934","https://openalex.org/W2085255857","https://openalex.org/W2096991001","https://openalex.org/W2101715273","https://openalex.org/W2122930216","https://openalex.org/W2128553167","https://openalex.org/W2137404654","https://openalex.org/W2140399799","https://openalex.org/W2158287171","https://openalex.org/W2170590512","https://openalex.org/W2336873088","https://openalex.org/W2766013461","https://openalex.org/W4245107297","https://openalex.org/W4246780690"],"related_works":["https://openalex.org/W2429715903","https://openalex.org/W3042479703","https://openalex.org/W4211022481","https://openalex.org/W4289028828","https://openalex.org/W2054139100","https://openalex.org/W2421625876","https://openalex.org/W3137322934","https://openalex.org/W1980438888","https://openalex.org/W2884875692","https://openalex.org/W2131115843"],"abstract_inverted_index":{"BACKGROUND:":[0],"Many":[1],"patients":[2,68,86,262],"with":[3,19,69,135],"chronic":[4,9,71,258],"idiopathic":[5,72,259],"urticaria":[6,73,260],"(also":[7],"called":[8],"spontaneous":[10],"urticaria)":[11],"do":[12],"not":[13],"have":[14],"a":[15,112,126],"response":[16],"to":[17,87,133],"therapy":[18,79],"H-antihistamines,":[20],"even":[21],"at":[22,98,199],"high":[23],"doses.":[24],"In":[25,51],"phase":[26,53],"2":[27],"trials,":[28],"omalizumab,":[29],"an":[30],"anti-IgE":[31],"monoclonal":[32],"antibody":[33],"[corrected]":[34],"that":[35],"targets":[36],"IgE":[37],"and":[38,41,63,188,255,278],"affects":[39],"mast-cell":[40],"basophil":[42],"function,":[43],"has":[44],"shown":[45],"efficacy":[46,62,118],"in":[47,67,125,151,165,172,177,183,190,228,234,240,261],"such":[48],"patients.":[49],"METHODS:":[50],"this":[52],"3,":[54],"multicenter,":[55],"randomized,":[56],"double-blind":[57],"study,":[58],"we":[59],"evaluated":[60],"the":[61,121,159,166,173,178,184,191,224,229,235,242,268],"safety":[64],"of":[65,96,100,208,217,257,270,273],"omalizumab":[66,97],"moderate-to-severe":[70],"who":[74,263],"remained":[75,265],"symptomatic":[76,266],"despite":[77,267],"H-antihistamine":[78],"(licensed":[80],"doses).":[81],"We":[82],"randomly":[83],"assigned":[84],"323":[85],"receive":[88],"three":[89],"subcutaneous":[90],"injections,":[91],"spaced":[92],"4":[93],"weeks":[94],"apart,":[95],"doses":[99,272],"75":[101],"mg,":[102,104],"150":[103],"or":[105,108,239,244],"300":[106],"mg":[107],"placebo,":[109],"followed":[110],"by":[111,276],"16-week":[113],"observation":[114],"period.":[115],"The":[116,143,206,215],"primary":[117],"outcome":[119],"was":[120,148,170,211,221,226],"change":[122,162],"from":[123,131,163],"baseline":[124,144,164],"weekly":[127,145,167],"itch-severity":[128,146,168],"score":[129,147,169],"(ranging":[130],"0":[132],"21,":[134],"higher":[136,227],"scores":[137],"indicating":[138],"more":[139],"severe":[140],"itching).":[141],"RESULTS:":[142],"approximately":[149],"14":[150],"all":[152],"four":[153],"study":[154],"groups.":[155,214],"At":[156],"week":[157,200],"12,":[158],"mean":[160],"(\u00b1SD)":[161],"-5.1\u00b15.6":[171],"placebo":[174,236],"group,":[175],"-5.9\u00b16.5":[176],"75-mg":[179,243],"group":[180,186,193,231,237,246],"(P=0.46),":[181],"-8.1\u00b16.4":[182],"150-mg":[185,245],"(P=0.001),":[187],"-9.8\u00b16.0":[189],"300-mg":[192,230],"(P<0.001).":[194],"Most":[195],"prespecified":[196],"secondary":[197],"outcomes":[198],"12":[201],"showed":[202],"similar":[203,212],"dose-dependent":[204],"effects.":[205],"frequency":[207,216],"adverse":[209,219],"events":[210,220],"across":[213],"serious":[218],"low,":[222],"although":[223],"rate":[225],"(6%)":[232],"than":[233],"(3%)":[238],"either":[241],"(1%":[247],"for":[248],"each).":[249],"CONCLUSIONS:":[250],"Omalizumab":[251],"diminished":[252],"clinical":[253],"symptoms":[254],"signs":[256],"had":[264],"use":[269],"approved":[271],"H-antihistamines.":[274],"(Funded":[275],"Genentech":[277],"Novartis":[279],"Pharma;":[280],"ClinicalTrials.gov":[281],"number,":[282],"NCT01292473.).":[283]},"counts_by_year":[{"year":2026,"cited_by_count":71},{"year":2025,"cited_by_count":81},{"year":2024,"cited_by_count":85},{"year":2023,"cited_by_count":57},{"year":2022,"cited_by_count":70},{"year":2021,"cited_by_count":89},{"year":2020,"cited_by_count":85},{"year":2019,"cited_by_count":65},{"year":2018,"cited_by_count":100},{"year":2017,"cited_by_count":91},{"year":2016,"cited_by_count":96},{"year":2015,"cited_by_count":85},{"year":2014,"cited_by_count":86},{"year":2013,"cited_by_count":34},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-21T09:56:26.102985","created_date":"2025-10-10T00:00:00"}